Share Name Share Symbol Market Type Share ISIN Share Description
NMC Health LSE:NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +30.00p +1.89% 1,616.00p 1,612.00p 1,614.00p 1,618.00p 1,577.00p 1,588.00p 88,835.00 16:35:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 880.9 85.4 44.3 36.5 3,301.26

NMC Health Share Discussion Threads

Showing 376 to 399 of 400 messages
Chat Pages: 16  15  14  13  12  11  10  9  8  7  6  5  Older
DateSubjectAuthorDiscuss
12/1/2017
08:08
HSBC lifts target from 1460p to 1800p.
philo124
05/1/2017
19:05
Seems to be heading north.Nice
blocker2
29/12/2016
17:27
Nice breakout; and strong into the close, too - augurs well, I think.
saucepan
29/12/2016
15:48
It is now.
philo124
28/12/2016
11:48
New ATH I think.
philo124
21/12/2016
10:49
Yes, me too. Good luck. £21/22 poss within a year.
philo124
21/12/2016
09:48
Hi folks. I took a position here yesterday. I thought 1500p looked a significant hurdle to have cleared.
saucepan
21/12/2016
08:50
Jefferies reiterate BUY. Ups target by 105p to 1930p.
aishah
19/12/2016
08:11
£20k up.
philo124
19/12/2016
08:09
£15!
philo124
14/12/2016
16:19
Thanks, was out all day.
philo124
14/12/2016
09:38
NMC Health plc (the "Company" or "NMC") Proposed acquisition of the Al Zahra Hospital for AED 2,058 million (approximately US$560 million) Strategic, accretive acquisition adds one of the largest private hospitals in the UAE and helps accelerate NMC's presence in the growing Sharjah healthcare market -- NMC Health plc (LSE:NMC), the leading integrated healthcare provider operating across the United Arab Emirates (the "UAE"), is pleased to announce the proposed acquisition (the "Acquisition"), subject to certain conditions and approvals, of Al Zahra Hospital in Sharjah (the "Al Zahra Hospital") from Gulf Medical Projects Company ("GMPC") for AED 2,058 million (approximately US$560 million). -- The Al Zahra Hospital is one of the largest private hospitals in the UAE, operating 137 active inpatient beds, serving approximately 400,000 outpatients and 23,000 inpatient bed days per year. -- The Acquisition complements the NMC group's (the "Group") existing network of seven out-patient medical centres in Sharjah, the third most populated emirate in the UAE, to further strengthen the Group's position as the largest private healthcare provider in the UAE and in the Gulf Cooperation Council (the "GCC") region. -- The Al Zahra Hospital has demonstrated a strong track record of growth and for the year ended December 2015 achieved revenue, EBITDA and net profit of US$130.4 million, US$43.5 million and US$38.8 million respectively. -- The Directors of NMC (the "Directors") have identified approximately US$6.5 million of annual cost synergy benefits from the second year post completion of the Acquisition onwards. In addition to these initial cost synergy benefits, the Directors believe that there are a number of other operational and synergistic benefits that will accrue over the medium term. -- In recent years, GMPC has invested significantly in the Al Zahra Hospital, including the addition of a new 17 storey block and three new operating theatres at a cost of US$33 million. The Directors believe that the recent investment in the 17 storey block will drive revenue growth over the medium and longer term as the additional added capacity drives increased patient numbers. In the future, the Directors believe that the Al Zahra Hospital has the ability to expand its capacity to approximately 200 beds with limited incremental investment required. -- The Acquisition is conditional, inter alia, on shareholder approval. As part of the financing of the Acquisition, the Company is undertaking a Placing of up to 9.99 per cent. of the issued share capital of the Company, as separately announced, and has also put in place new debt facilities. -- The Company has continued to see positive trading since its interim results announcement. The Directors reiterate the Company's standalone 2016 EBITDA guidance of approximately US$240 million.
aishah
04/11/2016
11:50
Agree totally.
philo124
04/11/2016
09:58
if I am right the regulatory changes has been around since June this year and this is nothing new. People may have to pay more for their health care but they still need their health care. Investors should stay calm and trust the good records of this stock imo.
joseph1818
04/11/2016
07:02
Their concerns over regulatory changes in Abu Dhabi re long term care.
philo124
04/11/2016
06:27
Yes, downgrade. No idea, will try to find out rationale.
philo124
03/11/2016
15:31
It has been going down all day today. Could this be to do with JP Morgan's 1420p target today, and how did they come up with such a target price. Anyone has other news??
joseph1818
02/11/2016
10:44
Let's hope it breaks £15 and stays above it.
philo124
19/10/2016
16:41
Good close. Raised my target from £15 to £16.50 fwiw.
philo124
14/10/2016
13:05
1000 bought at 1446p.
philo124
03/10/2016
21:13
No posts for 3 weeks. Good sign.
philo124
13/9/2016
07:52
Great, thanks. You were right about the correction.
philo124
13/9/2016
07:42
Jefferies reiterates BUY. Ups target(again!) to 1625 from 1570p.
aishah
08/9/2016
13:39
but pounded after the breakout yesterday . Should resume uptrend soon .
arja
Chat Pages: 16  15  14  13  12  11  10  9  8  7  6  5  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170119 23:35:21